Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals develops and sells stabilized hypochlorous acid (HOCl) products used in wound care, eye care, oral care, dermatology, podiatry, animal health care, and surface disinfection. The company operates through a U.S. parent with subsidiaries in Mexico and the Netherlands and sells through direct channels and partners in more than 55 countries.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueHOCl-based solutions and gels used for wound cleansing, irrigation, and skin protection.
Prescription and OTC products for eyelid, periocular, and blepharitis-related care.
Products for acne, scar management, atopic dermatitis, and skin irritation.
Hard-surface disinfectant and sanitizer products sold through partners and distributors.
HOCl products used in veterinary and other specialized care applications.
Customers
Sonoma sells to distributors, retail partners, healthcare channels, and other commercial customers that market or use HOCl-based products. Its end markets include human healthcare, consumer health, veterinary care, and surface disinfection, with demand coming from both domestic and international buyers. The company also relies on a small number of customers that can represent a meaningful share of revenue in a given period.
Buy HOCl products for resale across international and U.S. markets; important because Sonoma relies on partner-led commercialization.
Buy acne, wound care, and skin-care products through retailers and consumer health channels.
Use prescription and professional-grade eye, wound, and dermatology products for patient care.
Buy HOCl-based products for animal care and related hygiene applications.
Buy hard-surface disinfectants and sanitizers through partners such as MicroSafe.
Strategy
Sonoma's strategy centers on expanding distribution, securing regulatory clearances, and broadening the use of its HOCl platform across healthcare and consumer channels. It also seeks to deepen international reach, relaunch and extend product lines, and use partner-led commercialization to scale into new markets. The company continues to invest in product development and approvals to support market access and product breadth.
The business depends on channel partners to reach retailers, healthcare buyers, and international markets.
Approvals and clearances determine where HOCl products can be marketed and how broadly they can be sold.
A wider product set supports cross-selling across wound care, dermatology, eye care, and consumer channels.
International markets are a major revenue source and diversify demand beyond the U.S.
Geography
Sonoma has material international operations, with most revenue generated outside the United States and sales in over 55 countries. In the latest quarterly disclosures, Europe was the largest region, followed by the United States, Asia, Latin America, and the Rest of the World. The company also manufactures through its Mexico subsidiary and serves Europe through its Netherlands subsidiary.
Risks
Sonoma faces regulatory, quality, and commercialization risks because its HOCl products are sold in regulated healthcare and consumer categories across many countries. The company also depends on a small number of customers and third-party partners, which can create revenue volatility if demand shifts, approvals are delayed, or a partner underperforms. International exposure adds foreign exchange, tariff, and local compliance risk.
- Regulatory non-compliance or delayed approvalsImpact: HighLikelihood: Medium
HOCl products require FDA and international clearances, and changes in labeling or quality systems can delay commercialization.
Exposure: Product manufacturing and marketing
- Dependence on third-party partners and contractorsImpact: HighLikelihood: Medium
The company relies on collaborators, suppliers, and distributors for manufacturing and market access.
Exposure: Supply chain and commercialization
- Customer concentrationImpact: HighLikelihood: Medium
A small number of customers can account for a significant portion of revenue in a given year.
Exposure: Revenue concentration
- Product liability and recall riskImpact: HighLikelihood: Medium
Healthcare and disinfectant products can face recalls, claims, or reputational damage if performance or labeling is challenged.
Exposure: Brand and sales channels
- International operating riskImpact: MediumLikelihood: Medium
Most revenue is generated outside the U.S., increasing exposure to currency, tariffs, and local regulation.
Exposure
Accounting
Judgemental itemsSales through distributors, retailers, and international partners can create timing differences between shipment and end-demand.
Impact: Quarterly comparability and reported revenue
Customer concentration and international collections increase credit-risk judgment.
Impact: Net receivables and operating expense
Product shelf life, regulatory changes, and demand shifts can require reserve adjustments.
Impact: Gross margin and inventory carrying value
Loss history and uncertain future taxable income require management to assess realizability.
Impact: Income tax expense and balance sheet assets
The company has historically funded operations with equity issuances and related financing activities.
Impact: Share count, capital structure, and financing cash flows
Similar listed companies
Publicly listed companies with a comparable business focus.
Lexicon Pharmaceuticals, Inc
LXRX · Pharmaceutical Preparations
Lexicon Pharmaceuticals is a U.S.-based biopharmaceutical company focused on discovering, developing, and commercializing small-molecule medicines.
Alcon Inc
ALC · Ophthalmic Goods
Alcon Inc is a United States-based ophthalmic goods company focused on eye care products and surgical ophthalmology solutions.
Sonos Inc
SONO · Household Audio & Video Equipment
Sonos Inc designs and sells connected home audio products built around its wireless multi-room sound system.
Ecolab Inc
ECL · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Ecolab makes water treatment, cleaning, sanitizing, and infection-prevention solutions used by industrial, food, healthcare, hospitality, and life sciences customers.
Cencora, Inc.
COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora is a pharmaceutical sourcing and distribution company that sits between drug manufacturers and healthcare providers, moving branded, specialty,…
Anebulo Pharmaceuticals, Inc.
ANEB · Pharmaceutical Preparations
Last updated: 24/09/2026